Nimesulide

尼美舒利

Report date: 2023/02/27 20:00:18
NME

Base Information

Drug NameNimesulide
Drug Alias Name尼美舒列NimesulidumNimesulida4-硝基-2-苯氧甲烷磺酰苯胺Antifloxil +[17] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet aggregation inhibitorsHyaluronic acid modulatorsApoptosis stimulants +[4] 
TargetsCyclooxygenases
Therapy Area/IndicationsAcute PainPainPain, Postoperative +[6] 
Global Approved IndicationsAcute PainPain, PostoperativeDysmenorrhea +[5] 
Approved Indications in ChinaAcute PainPain, PostoperativeDysmenorrhea +[5] 
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesTipr Pharmaceutical Co Ltd
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsAcute PainPain, PostoperativeDysmenorrhea +[5] 
Inactive IndicationsPain

Other Information

ATC CodeM01AX17M02AA26
Related LinksWikipediaDrugBankKEGG